The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$20.03

Today's change+0.10 +0.50%
Updated January 18 3:38 PM EST. Delayed by at least 15 minutes.
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$20.03

Today's change+0.10 +0.50%
Updated January 18 3:38 PM EST. Delayed by at least 15 minutes.

Valeant Pharmaceuticals International Inc crosses above 20-day moving average

Valeant Pharmaceuticals International Inc is up today by $0.10 or 0.50% to $20.03 and crossing above its 20-day moving average. Over the last five days, shares have lost 1.38% and 84.46% over the last 52 weeks. This security has underperformed the S&P TSX by 113.31% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward2.96×
  • Forward PEG0.18×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$8.46
Updated January 18 3:38 PM EST. Delayed by at least 15 minutes.
S&P TSX0.35%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue2,4802,4202,3722,736
Total other revenue--------
Total revenue2,4802,4202,3722,736
Gross profit1,8221,7621,7422,060
Total cost of revenue658658630677
Total operating expense3,3432,3402,3052,542
Selling / general / administrative661672813743
Research & development10112410396
Depreciation / amortization807888695789
Interest expense (income), net operating--------
Unusual expense (income)1,1154442195
Other operating expenses, total1-452343
Operating income-8638166195
Interest income (expense), net non-operating-470-473-427-433
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,332-377-366-240
Income after tax-1,219-304-373-362
Income tax, total-113-737122
Net income-1,218-302-374-362
Total adjustments to net income--------
Net income before extra. items-1,218-302-374-362
Minority interest12-11
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1,218-302-374-362
Inc. avail. to common incl. extra. items-1,218-302-374-362
Diluted net income-1,218-302-374-362
Dilution adjustment--0----
Diluted weighted average shares350345345348
Diluted EPS excluding extraordinary itemsvalue per share-3.49-0.88-1.08-1.04
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-1.38-0.78-1.00-0.54